Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

Optimal two-stage designs for phase II clinical trials

1989 • 3,494 citations

Paclitaxel (Taxol)

1995 • 1,747 citations

Clinical toxicities encountered with paclitaxel (Taxol).

1993 • 682 citations

Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 2: Prognosis and staging

1993 • 253 citations

Malignant Mesothelioma of the Pleura

1988 • 170 citations

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

1994 • 136 citations

Malignant mesothelioma of the pleura

1988 • 72 citations

Chemotherapy in malignant mesothelioma: a review

1991 • 70 citations

Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

1992 • 62 citations

Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative group

1991 • 51 citations

Taxol resistant mutants of Chinese hamster ovary cells: Genetic biochemical, and cross‐resistance studies

1983 • 44 citations

Malignant mesothelioma: Diagnostic and management strategies for 1992

1993 • 43 citations

Malignant mesothelioma: diagnostic and management strategies for 1992.

1992 • 15 citations